1Pende D,Cantoni C, Rivera Pet al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin[J]. Eur J Immunol, 2001 ;31 (4) : 1076-1086.
2Daniela Pende, Panla Rivera, Stefania Marcenaro et al. Major histocompatibility complex class Ⅰ -related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity [ J ]. Imunology, 2002 ; 62 : 6178-6186.
3Helmut Rainer Salih, Holger Antropius, Friederike Gieseke et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia[J]. Blood,2003; 102(4) : 1389-13%.
4Pegah Nowbakht, Mihai-Constantin S Ionescu, Andreas Rohner et al. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomocytic cells but at low levels in acute myeloid leukemias[J].Blood, 2005 ; 105 (9) : 3615-3622.
5Boissel N, Rea D,Tienq V et at. BCR/ABL oncogene directly controls MHC class Ⅰ chain-related molecule. A expression in chronic myelogenous leukemia[J]. J Immunol, 2006 ; 176(8) : 5108-5116.
